TWD 21.3
(-2.29%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 286.09 Million | 129.42 Million | 176.8 Million | 41.36 Million | 116.76 Million |
Net Income | 67.65 Million | 85.01 Million | -16.7 Million | 38.57 Million | 41.78 Million |
Depreciation & Amortization | 51.79 Million | 67.92 Million | 72.69 Million | 69.28 Million | 70.68 Million |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | 164.47 Million | -28.64 Million | 144.29 Million | -53.8 Million | -78.74 Million |
Other non-cash items | 13.19 Million | 19.68 Million | 18.57 Million | 14.13 Million | 83.04 Million |
Investing Cash Flow | 1.15 Million | 484.19 Million | -517.94 Million | -296.12 Million | 157.49 Million |
Investments in PPE | -4.3 Million | -8.07 Million | -162.37 Million | -113.17 Million | -73.16 Million |
Acquisitions | 22 Thousand | 8.67 Million | - | - | - |
Investment purchases | 4.4 Million | 492.41 Million | -346.47 Million | -171.84 Million | - |
Sales/Maturities of investments | - | 492.41 Million | - | -171.84 Million | 284.59 Million |
Other Investing Activities | 726 Thousand | -11.83 Million | -11.4 Million | -13.14 Million | 230.65 Million |
Financing Cash Flow | -305.49 Million | -724.4 Million | 458.31 Million | 467.56 Million | -228.37 Million |
Debt repayment | -216.15 Million | -858.39 Million | -489.91 Million | -493.45 Million | -26.06 Million |
Dividends payments | -77.33 Million | -15.46 Million | -25.13 Million | -30.93 Million | -49.57 Million |
Common Stock Repurchased | - | - | - | - | -21.3 Million |
Common Stock Issuance | - | - | - | - | - |
Other Financing Activities | -12 Million | 150.45 Million | -256 Thousand | 12.78 Million | -131.42 Million |
Accounts receivables | 5.78 Million | -9.64 Million | 25.09 Million | -28.03 Million | -10.08 Million |
Accounts payables | 28.48 Million | - | - | - | - |
Inventory | 85.11 Million | 77.1 Million | 21.63 Million | -128.86 Million | -43.37 Million |
Other working capital | 48.24 Million | 55.44 Million | -2.2 Million | -51.17 Million | -25.28 Million |
Cash at beginning of period | 512.98 Million | 624.29 Million | 506.9 Million | 294.74 Million | 248.44 Million |
Cash at end of period | 492.59 Million | 512.98 Million | 624.29 Million | 506.9 Million | 294.74 Million |
Capital Expenditure | -4.3 Million | -8.07 Million | -162.37 Million | -113.17 Million | -73.16 Million |
Effect of forex changes on cash | -2.14 Million | -515 Thousand | 214 Thousand | -648 Thousand | 408 Thousand |
Net cash flow / Change in cash | -20.39 Million | -111.3 Million | 117.38 Million | 212.16 Million | 46.29 Million |
Free Cash Flow | 281.79 Million | 121.35 Million | 14.42 Million | -71.81 Million | 43.6 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 16.68 Million | 16.68 Million | 19.28 Million | 67.65 Million | 19.28 Million | 7.7 Million |
Depreciation & Amortization | 11.89 Million | 11.89 Million | 12.38 Million | 51.79 Million | 12.38 Million | 13.5 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 18.24 Million | 18.24 Million | 13.31 Million | 164.47 Million | 13.31 Million | 56.25 Million |
Other non-cash items | -11.79 Million | -11.79 Million | 49.01 Million | 13.19 Million | 49.01 Million | -28.42 Million |
Investing Cash Flow | -44.5 Thousand | -44.5 Thousand | -3.13 Million | 1.15 Million | -3.13 Million | 3.71 Million |
Investments in PPE | -501.49 Thousand | -501.49 Thousand | -886 Thousand | -4.3 Million | -886 Thousand | -1.26 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | 4.4 Million | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 456.99 Thousand | 456.99 Thousand | -2.25 Million | 726 Thousand | -2.25 Million | 4.98 Million |
Financing Cash Flow | -59.62 Million | -59.62 Million | -37.52 Million | -305.49 Million | -37.52 Million | -115.22 Million |
Debt repayment | -59.29 Million | - | - | -216.15 Million | - | - |
Dividends payments | -65.73 Million | -32.86 Million | - | -77.33 Million | - | -38.66 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -26.75 Million | -26.75 Million | -37.52 Million | -12 Million | -37.52 Million | -76.55 Million |
Accounts receivables | -6.59 Million | -6.59 Million | 3.52 Million | 5.78 Million | 3.52 Million | -632.5 Thousand |
Accounts payables | -8.79 Million | - | - | - | - | - |
Inventory | 24.15 Million | 24.15 Million | 14.41 Million | 85.11 Million | 14.41 Million | 28.14 Million |
Other working capital | 677 Thousand | 677 Thousand | -4.62 Million | 48.24 Million | -4.62 Million | 28.74 Million |
Cash at beginning of period | 492.59 Million | - | - | 512.98 Million | - | - |
Cash at end of period | -23.45 Million | -23.45 Million | 54.2 Million | 492.59 Million | 54.2 Million | -64.4 Million |
Capital Expenditure | -501.49 Thousand | -501.49 Thousand | -886 Thousand | -4.3 Million | -886 Thousand | -1.26 Million |
Effect of forex changes on cash | 1.18 Million | 1.18 Million | 870 Thousand | -2.14 Million | 870 Thousand | -1.94 Million |
Net cash flow / Change in cash | -516.05 Million | -23.45 Million | 54.2 Million | -20.39 Million | 54.2 Million | -64.4 Million |
Free Cash Flow | 34.52 Million | 34.52 Million | 93.11 Million | 281.79 Million | 93.11 Million | 47.78 Million |
RGR
0KEJ
MEDICAB
7409
8031
RDWR